Therapy Areas: Oncology
29 January 2020 - Gene therapy company Genprex Inc (NASDAQ:GNPX) revealed on Tuesday the completion of the sale of an aggregate of 7,620,000 shares of its common stock.The company issued the common st...
28 January 2020 - Biopharmaceutical company Zymeworks Inc (NYSE:ZYME) revealed on Monday the completion of its underwritten public offering of 5,824,729 common shares, including the exercise in full o...
28 January 2020 - AstraZeneca Plc (STO:AZN)(LON:SZN), a global, science-led biopharmaceutical company, announced on Monday that high-level results from the phase III THALES trial showed that the compa...
28 January 2020 - AstraZeneca Plc (STO:AZN)(LON:AZN) announced on Monday that it has agreed to sell the global commercial rights to Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chl...
28 January 2020 - ImmunoGen Inc (Nasdaq:IMGN), a developer of antibody-drug conjugates (ADCs) for the treatment of cancer, revealed on Monday the completion of its underwritten public offering of 24,5...
27 January 2020 - - US-based clinical stage biotechnology company Moderna, Inc., (NASDAQ: MRNA) has forged a new collaboration to develop an mRNA vaccine against the novel coronavirus (2019-nCoV), the...